TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmaq Analytiq AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
85,627
|
83,239
|
84,703 |
Financial expenses |
537
|
514
|
84 |
Earnings before taxes |
-691
|
-6,744
|
-3,959 |
Total assets |
39,878
|
53,160
|
58,666 |
Current assets |
18,630
|
28,293
|
31,063 |
Current liabilities |
19,597
|
30,660
|
37,469 |
Equity capital |
20,065
|
22,055
|
20,771 |
- share capital |
1,086
|
1,163
|
1,128 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.3%
|
41.5%
|
35.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
-0.8%
|
-8.1%
|
-4.7% |
Return on assets (ROA) |
-0.4%
|
-11.7%
|
-6.6% |
Current ratio |
95.1%
|
92.3%
|
82.9% |
Return on equity (ROE) |
-3.4%
|
-30.6%
|
-19.1% |
Change turnover |
7,903
|
-4,088
|
27,929 |
Change turnover % |
10%
|
-5%
|
49% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.